Banbury Partners’s Clarivate CLVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-433,222
Closed -$11.4M 2
2021
Q1
$11.4M Sell
433,222
-432,166
-50% -$11.8M 7.1% 6
2020
Q4
$25.7M Sell
865,388
-2,870
-0.3% -$84.8K 7.67% 3
2020
Q3
$26.9M Buy
868,258
+303,139
+54% +$8.2M 8.36% 3
2020
Q2
$12.6M Sell
565,119
-129,104
-19% -$2.92M 5.17% 12
2020
Q1
$14.4M Sell
694,223
-1,071,123
-61% -$21.4M 9.32% 7
2019
Q4
$29.7M Buy
1,765,346
+190,944
+12% +$3.22M 8.9% 1
2019
Q3
$26.6M Buy
+1,574,402
New +$26.1M 10.02% 3

Other funds holding CLVT

Banbury Partners's CLVT Position: Q2 2021 in Review

Banbury Partners sold out of Clarivate (CLVT) in Q2 2021, closing a stake of 433,222 shares — an estimated $11.4M sold.

Banbury Partners first reported a position in CLVT in Q3 2019 and held it in 7 quarters. The position peaked at $29.7M in Q4 2019. 289 funds tracked by Wall St. Rank hold CLVT as of Q2 2021.

  • Banbury Partners reported no remaining Clarivate position as of Q2 2021 after selling out during the quarter.
  • Banbury Partners sold 433,222 Clarivate shares in Q2 2021, an estimated $11.4M.
  • Banbury Partners first reported a position in Clarivate in Q3 2019 and held it in 7 quarters.
  • Banbury Partners's Clarivate position peaked at $29.7M in Q4 2019.
  • 289 funds tracked by Wall St. Rank held Clarivate as of Q2 2021.

Based on Banbury Partners's 13F filing for Q2 2021.